{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:18:14Z","timestamp":1783383494594,"version":"3.54.6"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008150","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000}}],"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","award":["SPARK Translational Research Program"],"award-info":[{"award-number":["SPARK Translational Research Program"]}],"id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","award":["Department of Medicine TRAM Grant"],"award-info":[{"award-number":["Department of Medicine TRAM Grant"]}],"id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006521","name":"School of Medicine, Stanford University","doi-asserted-by":"publisher","award":["CHRI grant"],"award-info":[{"award-number":["CHRI grant"]}],"id":[{"id":"10.13039\/100006521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI123594"],"award-info":[{"award-number":["AI123594"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001444"],"award-info":[{"award-number":["KL2TR001444"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI133394"],"award-info":[{"award-number":["AI133394"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI141210"],"award-info":[{"award-number":["AI141210"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1132796"],"award-info":[{"award-number":["OPP1132796"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI130807"],"award-info":[{"award-number":["AI130807"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002655","name":"Beckman Coulter Foundation","doi-asserted-by":"publisher","award":["Young Investigator Award"],"award-info":[{"award-number":["Young Investigator Award"]}],"id":[{"id":"10.13039\/100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI133394"],"award-info":[{"award-number":["AI133394"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI141210"],"award-info":[{"award-number":["AI141210"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008150","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T17:51:49Z","timestamp":1584726709000},"page":"e0008150","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity"],"prefix":"10.1371","volume":"14","author":[{"given":"Gretchen","family":"Ehrenkaufer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Kangussu-Marcolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corin V.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-4564","authenticated-orcid":true,"given":"Matthew S.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"DeRisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn","family":"Gisselberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-9577","authenticated-orcid":true,"given":"Steven C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Hervella","family":"Company","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-0306","authenticated-orcid":true,"given":"Upinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"issue":"10159","key":"pntd.0008150.ref001","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators GBDCoD","year":"2018","journal-title":"Lancet"},{"issue":"9306","key":"pntd.0008150.ref002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(02)07744-9","article-title":"Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study","volume":"359","author":"DS Berkman","year":"2002","journal-title":"The Lancet"},{"key":"pntd.0008150.ref003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"JA DiMasi","year":"2016","journal-title":"J Health Econ"},{"issue":"7","key":"pntd.0008150.ref004","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/nmicrobiol.2016.92","article-title":"Drug resistance in eukaryotic microorganisms","volume":"1","author":"AH Fairlamb","year":"2016","journal-title":"Nat Microbiol"},{"issue":"42","key":"pntd.0008150.ref005","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"J Janes","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0008150.ref006","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fcimb.2018.00276","article-title":"High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites","volume":"8","author":"GM Ehrenkaufer","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"pntd.0008150.ref007","doi-asserted-by":"crossref","first-page":"e108694","DOI":"10.1371\/journal.pone.0108694","article-title":"A multicenter phase I\/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia","volume":"9","author":"AD Schimmer","year":"2014","journal-title":"PLoS One"},{"issue":"7\u201310","key":"pntd.0008150.ref008","first-page":"114","article-title":"Anisomycin in intestinal amebiasis; study of 30 clinical cases","volume":"21","author":"R. Gonzalez Constandse","year":"1956","journal-title":"Prensa Med Mex"},{"issue":"2","key":"pntd.0008150.ref009","first-page":"115","article-title":"Treatment of vaginal trichomoniasis with 2-acetylamino-5-nitrothiazole (aminitrozole) given orally","volume":"33","author":"RR Willcox","year":"1957","journal-title":"Br J Vener Dis"},{"key":"pntd.0008150.ref010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-813712-3.00005-9","volume-title":"Human Parasitology","author":"BJ Bogitsh","year":"2019"},{"issue":"12","key":"pntd.0008150.ref011","doi-asserted-by":"crossref","first-page":"e1001920","DOI":"10.1371\/journal.pmed.1001920","article-title":"World Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data Synthesis","volume":"12","author":"PR Torgerson","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"pntd.0008150.ref012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.patbio.2012.03.002","article-title":"Pathogenic free-living amoebae: epidemiology and clinical review","volume":"60","author":"H Trabelsi","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"pntd.0008150.ref013","doi-asserted-by":"crossref","DOI":"10.30875\/4348b814-en","volume-title":"World malaria report 2016","author":"WH Organization","year":"2016"},{"issue":"9888","key":"pntd.0008150.ref014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"KL Kotloff","year":"2013","journal-title":"Lancet"},{"key":"pntd.0008150.ref015","author":"S Krishna","year":"2019","journal-title":"African trypanosomiasis: Clinical manifestations, diagnosis, and treatment"},{"key":"pntd.0008150.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"J Pepin","year":"1994","journal-title":"Adv Parasitol"},{"issue":"10","key":"pntd.0008150.ref017","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The Long Wait for a New Drug for Human African Trypanosomiasis","volume":"34","author":"CH Baker","year":"2018","journal-title":"Trends Parasitol"},{"key":"pntd.0008150.ref018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-12-813712-3.00011-4","volume-title":"Human Parasitology","author":"BJ Bogitsh","year":"2019"},{"issue":"2","key":"pntd.0008150.ref019","doi-asserted-by":"crossref","first-page":"e30949","DOI":"10.1371\/journal.pone.0030949","article-title":"P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action","volume":"7","author":"LM Sanz","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0008150.ref020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"A Debnath","year":"2012","journal-title":"Nat Med"},{"issue":"5","key":"pntd.0008150.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02051-18","article-title":"Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris","volume":"9","author":"MT Laurie","year":"2018","journal-title":"MBio"},{"issue":"5","key":"pntd.0008150.ref022","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.46.5.1510-1515.2002","article-title":"In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum","volume":"46","author":"S Gupta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pntd.0008150.ref023","doi-asserted-by":"crossref","first-page":"e0004659","DOI":"10.1371\/journal.pntd.0004659","article-title":"High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni","volume":"10","author":"NR Mansour","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0008150.ref024","first-page":"490","article-title":"Acute and chronic toxicity of anisomycin in experimental animals","volume":"5","author":"JF Gardocki","year":"1955","journal-title":"Antibiot Chemother (Northfield)"},{"key":"pntd.0008150.ref025","unstructured":"Health NIfOSa. Registry of Toxic Effects of Chemical Substances1987."},{"issue":"12","key":"pntd.0008150.ref026","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1182\/blood-2006-10-047951","article-title":"Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma","volume":"109","author":"S Trudel","year":"2007","journal-title":"Blood"},{"issue":"10","key":"pntd.0008150.ref027","first-page":"540","article-title":"Chemotherapeutic and tolerance studies on amino-nitro-thiazoles","volume":"5","author":"AC Cuckler","year":"1955","journal-title":"Antibiot Chemother (Northfield)"},{"issue":"95","key":"pntd.0008150.ref028","doi-asserted-by":"crossref","first-page":"92479","DOI":"10.1039\/C6RA16083B","article-title":"Determination of anisomycin in tissues and serum by LC-MS\/MS: application to pharmacokinetic and distribution studies in rats","volume":"6","author":"L Toli\u0107","year":"2016","journal-title":"RSC Advances"},{"key":"pntd.0008150.ref029","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1182\/blood.V118.21.2580.2580","article-title":"Predicting Clinical Dose-Exposure and Exposure-Response Relationships of Pan-Antiapoptotic BCL-2 Family Inhibitor Obatoclax in MLL Rearranged Infant Leukemias From Preclinical Disease Models and Adult Experience","volume":"118","author":"JS Barrett","year":"2011","journal-title":"Blood"},{"issue":"3","key":"pntd.0008150.ref030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bjp.0703614","article-title":"Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines","volume":"131","author":"B Montaner","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"42","key":"pntd.0008150.ref031","doi-asserted-by":"crossref","first-page":"35324","DOI":"10.1074\/jbc.M112.392142","article-title":"Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection","volume":"287","author":"OV Denisova","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"pntd.0008150.ref032","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.parint.2015.05.004","article-title":"In vitro antiparasitic activity of microbial pigments and their combination with phytosynthesized metal nanoparticles","volume":"64","author":"S Rahul","year":"2015","journal-title":"Parasitol Int"},{"issue":"1","key":"pntd.0008150.ref033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2012.05.002","article-title":"In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1","volume":"95","author":"NI Torres","year":"2012","journal-title":"Antiviral Res"},{"issue":"3","key":"pntd.0008150.ref034","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02227-16","article-title":"Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments","volume":"61","author":"FS Varghese","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pntd.0008150.ref035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/AAC.00618-10","article-title":"High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements","volume":"55","author":"CZ Chen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"pntd.0008150.ref036","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"D Plouffe","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"pntd.0008150.ref037","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2012","journal-title":"Nucleic Acids Research"},{"issue":"11","key":"pntd.0008150.ref038","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","article-title":"Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors","volume":"11","author":"A Singh","year":"2016","journal-title":"ACS Chem Biol"},{"key":"pntd.0008150.ref039","doi-asserted-by":"crossref","first-page":"104558","DOI":"10.1016\/j.antiviral.2019.104558","article-title":"The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors","volume":"169","author":"YJ Kim","year":"2019","journal-title":"Antiviral Res"},{"issue":"5","key":"pntd.0008150.ref040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QCO.0b013e32834ad401","article-title":"New approaches to the treatment of giardiasis","volume":"24","author":"N Tejman-Yarden","year":"2011","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"3","key":"pntd.0008150.ref041","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug Resistance in the Microaerophilic Parasite Giardia lamblia","volume":"2","author":"D. Leitsch","year":"2015","journal-title":"Curr Trop Med Rep"},{"issue":"1","key":"pntd.0008150.ref042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2007.00232.x","article-title":"Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea","volume":"50","author":"GS Visvesvara","year":"2007","journal-title":"FEMS immunology and medical microbiology"},{"issue":"6","key":"pntd.0008150.ref043","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/cid\/civ1021","article-title":"Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case","volume":"62","author":"JR Cope","year":"2016","journal-title":"Clin Infect Dis"},{"key":"pntd.0008150.ref044","article-title":"Identification of plicamycin, TG02, panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia","author":"M Kangussu-Marcolino","year":"2019","journal-title":"International Journal for Parasitology: Drugs and Drug Resistance"},{"issue":"5","key":"pntd.0008150.ref045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance","volume":"61","author":"N Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pntd.0008150.ref046","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"W Wang","year":"2012","journal-title":"Parasitol Res"},{"issue":"4","key":"pntd.0008150.ref047","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"L Pica-Mattoccia","year":"2004","journal-title":"Int J Parasitol"},{"issue":"10","key":"pntd.0008150.ref048","doi-asserted-by":"crossref","first-page":"e3265","DOI":"10.1371\/journal.pntd.0003265","article-title":"Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel","volume":"8","author":"RS Kasinathan","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0008150.ref049","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/151.6.1130","article-title":"Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo","volume":"151","author":"SH Xiao","year":"1985","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0008150.ref050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s13071-018-3132-x","article-title":"Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy","volume":"11","author":"V Buchter","year":"2018","journal-title":"Parasit Vectors"},{"issue":"Pt 1","key":"pntd.0008150.ref051","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0031182000007137","article-title":"Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections","volume":"122","author":"S William","year":"2001","journal-title":"Parasitology"},{"issue":"2","key":"pntd.0008150.ref052","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: First Global Approval","volume":"79","author":"ED Deeks","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"pntd.0008150.ref053","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"EG Tse","year":"2019","journal-title":"Malar J"},{"issue":"15","key":"pntd.0008150.ref054","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1021\/jm200543y","article-title":"Antimalarial activity of natural and synthetic prodiginines","volume":"54","author":"K Papireddy","year":"2011","journal-title":"J Med Chem"},{"issue":"2","key":"pntd.0008150.ref055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-2952(90)90691-D","article-title":"Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis","volume":"40","author":"RM Ekong","year":"1990","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"pntd.0008150.ref056","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2010.05.076","article-title":"Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children","volume":"139","author":"SR Moore","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"pntd.0008150.ref057","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/321008","article-title":"Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide","volume":"184","author":"JF Rossignol","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0008150.ref058","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01505-17","article-title":"A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box","volume":"62","author":"RS Jumani","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pntd.0008150.ref059","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood-2011-11-391037","article-title":"Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma","volume":"119","author":"Y Oki","year":"2012","journal-title":"Blood"},{"key":"pntd.0008150.ref060","first-page":"103","article-title":"Action of anisomycin in amebiasis and giardiasis","volume":"25","author":"L. Martin Abreu","year":"1962","journal-title":"Rev Med Hosp Gen"},{"issue":"2","key":"pntd.0008150.ref061","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2008-02-137943","article-title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","volume":"113","author":"SM O'Brien","year":"2009","journal-title":"Blood"},{"key":"pntd.0008150.ref062","unstructured":"WHO. 2019. Available from: https:\/\/www.who.int\/schistosomiasis\/strategy\/en\/."},{"issue":"4","key":"pntd.0008150.ref063","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1574-6976.2006.00023.x","article-title":"Acanthamoeba: biology and increasing importance in human health","volume":"30","author":"NA Khan","year":"2006","journal-title":"FEMS microbiology reviews"},{"issue":"1","key":"pntd.0008150.ref064","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4269\/ajtmh.2003.68.65","article-title":"Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes","volume":"68","author":"GC Booton","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0008150.ref065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijantimicag.2006.08.024","article-title":"Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence","volume":"29","author":"ME Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"pntd.0008150.ref066","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3349\/ymj.2010.51.1.121","article-title":"Evaluation of three different methods to establish animal models of Acanthamoeba keratitis","volume":"51","author":"M Ren","year":"2010","journal-title":"Yonsei Med J"},{"issue":"12","key":"pntd.0008150.ref067","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio837","article-title":"Drug discovery and development for neglected parasitic diseases","volume":"2","author":"AR Renslo","year":"2006","journal-title":"Nat Chem Biol"},{"issue":"4","key":"pntd.0008150.ref068","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0035-9203(78)90144-X","article-title":"A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba","volume":"72","author":"LS Diamond","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"pntd.0008150.ref069","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/AAC.02254-13","article-title":"In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts","volume":"58","author":"A Debnath","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pntd.0008150.ref070","doi-asserted-by":"crossref","first-page":"e0006104","DOI":"10.1371\/journal.pntd.0006104","article-title":"CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)","volume":"11","author":"A Debnath","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008150.ref071","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fmicb.2018.00414","article-title":"In Vitro Efficacy of Ebselen and BAY 11\u20137082 Against Naegleria fowleri","volume":"9","author":"A Debnath","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"pntd.0008150.ref072","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.04.007","article-title":"Novel culture medium for the axenic growth of Balamuthia mandrillaris","volume":"82","author":"LF Lares-Jimenez","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"pntd.0008150.ref073","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exppara.2009.09.013","article-title":"Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets","volume":"126","author":"R Siddiqui","year":"2010","journal-title":"Exp Parasitol"},{"issue":"4 suppl","key":"pntd.0008150.ref074","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1074\/mcp.M116.064550","article-title":"The Prenylated Proteome of Plasmodium falciparum Reveals Pathogen-specific Prenylation Activity and Drug Mechanism-of-action","volume":"16","author":"JE Gisselberg","year":"2017","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"pntd.0008150.ref075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2307\/3280632","article-title":"Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing","volume":"67","author":"PF Basch","year":"1981","journal-title":"J Parasitol"},{"issue":"6","key":"pntd.0008150.ref076","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers","volume":"75","author":"H Hirumi","year":"1989","journal-title":"J Parasitol"},{"issue":"7","key":"pntd.0008150.ref077","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1128\/AAC.02576-14","article-title":"Hsp90 inhibitors as new leads to target parasitic diarrheal diseases","volume":"58","author":"A Debnath","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0008150.ref078","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/AAC.03342-14","article-title":"A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis","volume":"59","author":"W Wu","year":"2015","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"pntd.0008150.ref079","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"K Bessoff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pntd.0008150.ref080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057114556236","article-title":"Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei","volume":"20","author":"J Faria","year":"2015","journal-title":"J Biomol Screen"},{"issue":"17","key":"pntd.0008150.ref081","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cmdc.201800404","article-title":"Brain-Penetrant Triazolopyrimidine and Phenylpyrimidine Microtubule Stabilizers as Potential Leads to Treat Human African Trypanosomiasis","volume":"13","author":"L Monti","year":"2018","journal-title":"ChemMedChem"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008150","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T17:41:10Z","timestamp":1585762870000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008150"}},"subtitle":[],"editor":[{"given":"Alvaro","family":"Acosta-Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008150","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008150","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}